Use of genetic markers for identifying the response to interferon treatment in Multiple Sclerosis patients

Details for Australian Patent Application No. 2009273277 (hide)

Owner MERCK SERONO S.A.

Inventors Monnet, Emmanuel; Bouzekri, Nourdine

Agent Griffith Hack

Pub. Number AU-A-2009273277

PCT Pub. Number WO2010/010057

Priority 08104874.6 24.07.08 EP; 61/135,970 25.07.08 US

Filing date 20 July 2009

Wipo publication date 28 January 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2010/010057 Priority application(s): WO2010/010057

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009273280-Telephony fraud prevention

2009273276-Process for the preparation of esomeprazole magnesium in a stable form